Log inSign up
user avatar
Celcuity
@celcuity
Clinical-stage biotechnology company developing targeted therapies for cancer. Our lead compound, gedatolisib, is a potential first-in-class PI3K-mTOR inhibitor
Minneapolis, MN
celcuity.com
Joined August 2022
83
Following
238
Followers

@celcuity hasn’t posted

When they do, their posts will show up here.